HOME >> MEDICINE >> NEWS
ReQuip cuts risk of dyskinesias by 15-fold in early Parkinson's disease

Vancouver, Canada - A landmark, multinational, 5-year study shows that the dopamine-agonist ReQuip® (ropinirole hydrochloride, SmithKline Beecham) is associated with a much lower incidence of dyskinesias than L-dopa, and has comparable efficacy to L-dopa in the management of early Parkinson's Disease. The results of this exciting study are released today for the first time at the XIII International Congress on Parkinson's Disease (ICPD), Vancouver, 24-28 July, 1999.

"This landmark study should affect the future management of Parkinson's Disease. The data demonstrate that ropinirole is a first-line option for the initial treatment of early Parkinson's Disease," commented lead author of the study, Professor Olivier Rascol, Professor of Pharmacology at the Centre Hospitalier Universitaire, Toulouse, France.

"This is important news for patients, as we can now hope for good control of their symptoms with less risk of dyskinesias," concluded Dr Donald Calne, Chairman of the ICPD, and Director of the Neurodegenerative Disorders Centre, University of British Columbia, Vancouver, Canada.

The 268 patients participating in this double-blind controlled study, conducted in Europe, Israel and Canada, were randomised to receive either ReQuip® or L-dopa -- the current standard therapy. Both treatment groups were allowed to receive supplementary L-dopa if required.

The study demonstrated that the probability (odds ratio) of developing dyskinesias was 3.8 times higher for patients receiving L-dopa (incidence 46%) than for patients receiving ReQuip®, either alone or with additional L-dopa (incidence 20%). In patients who completed the trial on ReQuip® alone, the benefit was found to be even greater, with the relative probability of dyskinesias 15.2 times higher in the L-dopa group (incidence 36%) than the ReQuip® group (incidence 5%).

Over the 5-year study period, both groups of patients experienced similar control of their symptoms. A
'"/>

Contact: Kate Davies (Vancouver)
alexa@meditech.co.uk
44-780-840-345
MediTech Media Ltd.
26-Jul-1999


Page: 1 2

Related medicine news :

1. Clozapine effective for controlling dyskinesias in people with severe Parkinsons
2. New marker for early diagnosis of kidney failure identified
3. English-speaking Hispanic youth more likely to have sex early
4. Inpatient smoking cessation counseling is associated with early differences in mortality
5. Study finds no reason for expectant mothers to shy away from early epidurals
6. No increase in C-sections when epidural analgesia given early in labor
7. Radiologists offer non-surgical treatment for early-stage liver cancer
8. Researchers confirm Vioxx nearly doubled cardiovascular risks in cancer prevention study
9. A new method for early detection of disease outbreaks
10. UCLA study: Nearly a third of drug ads in medical journals contain no references for medical claims
11. Morbidly obese pay nearly twice as much for health care

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: ReQuip cuts risk dyskinesias fold early Parkinson disease

(Date:3/30/2015)... San Marcos, CA (PRWEB) March 30, 2015 ... Marcos, California, offers no cost 15 minute second opinion ... dental work. , β€œThe statistics on dental second opinions ... a second opinion on major dental works. Only 6%” – ... get a second opinion even when fully trusting the dental ...
(Date:3/30/2015)... (PRWEB) March 30, 2015 Zane ... for small businesses, announced its latest webinar "Can ... on webcast. This discussion was conducted by ... to Zane Benefits, there is a massive transition ... Instead of selecting a group health plan, employers ...
(Date:3/30/2015)... March 30, 2015 The partners of ... the grand opening of the Bella Diosa Laser Med ... the finest in laser med spa treatments. , February ... Spa and the partnership bridges the medical services provided ... treatments provided by Bella Diosa for both women and ...
(Date:3/30/2015)... New York, New York (PRWEB) March 30, 2015 ... has been filed in California Superior Court on ... a serious heart birth defect after his mother was ... pregnancy. According to the March 6th filing in Alameda ... to alleviate nausea and vomiting that she experienced in ...
(Date:3/30/2015)... The fertility team at Ada ... asked questions to give intended parents across the globe ... , After unveiling the most affordable, non-sharing ... IVF clinic has witnessed an increase in fertility patients. ... provides attentive reproductive care β€” with all-inclusive IVF treatment ...
Breaking Medicine News(10 mins):Health News:Allred Dental Offers Complimentary 15 Minute Consults with Dr. Jeffrey Allred in San Marcos, CA 2Health News:Zane Benefits New Webinar Premium Reimbursement Webinar Now Available On-Demand 2Health News:Yonkers Celebrates the Grand Opening of Bella Diosa 2Health News:New Zofran Lawsuit Alleging Birth Defects Filed This Month in California Superior Court 2Health News:New Zofran Lawsuit Alleging Birth Defects Filed This Month in California Superior Court 3Health News:New Zofran Lawsuit Alleging Birth Defects Filed This Month in California Superior Court 4Health News:Top Fertility Clinic in Cyprus Answers Key Questions on Egg Donation Process 2Health News:Top Fertility Clinic in Cyprus Answers Key Questions on Egg Donation Process 3Health News:Top Fertility Clinic in Cyprus Answers Key Questions on Egg Donation Process 4
(Date:3/30/2015)... Research and Markets ( ... the "Urological Catheters - Global Strategic ... This report analyzes the worldwide ... and US$ Thousands by the following Product ... Catheters), and Urinary Catheters (Foley Catheters, Intermittent ...
(Date:3/30/2015)... , March 30, 2015  Caris Life Sciences® today ... targeting specific pathways may have potentially significant benefit in ... study results were highlighted today in an oral presentation ... Oncology (SGO) 2015 Annual Meeting on Women,s Cancer in ... study is one of four presented at the annual ...
(Date:3/30/2015)... Calif. , March 30, 2015  Cochlear ... has decided to leave Cochlear to join Valencia ... and friend, Jeff Greiner , who is ... Chief of Market Development and will be responsible ... of Valencia,s coin-sized neuromodulation ...
Breaking Medicine Technology:Urological Catheters - Global Strategic Business Report 2015-2020: Burgeoning Ageing Populace to Propel Catheter Usage 2Urological Catheters - Global Strategic Business Report 2015-2020: Burgeoning Ageing Populace to Propel Catheter Usage 3Urological Catheters - Global Strategic Business Report 2015-2020: Burgeoning Ageing Populace to Propel Catheter Usage 4Urological Catheters - Global Strategic Business Report 2015-2020: Burgeoning Ageing Populace to Propel Catheter Usage 5Urological Catheters - Global Strategic Business Report 2015-2020: Burgeoning Ageing Populace to Propel Catheter Usage 6Urological Catheters - Global Strategic Business Report 2015-2020: Burgeoning Ageing Populace to Propel Catheter Usage 7Caris Life Sciences' Multiplatform Tumor Profiling Enhances Understanding of Molecular Drivers and Treatment Selection in Uterine Carcinomas 2Caris Life Sciences' Multiplatform Tumor Profiling Enhances Understanding of Molecular Drivers and Treatment Selection in Uterine Carcinomas 3Caris Life Sciences' Multiplatform Tumor Profiling Enhances Understanding of Molecular Drivers and Treatment Selection in Uterine Carcinomas 4Cochlear VP of U.S. Sales Jerry Schloffman Accepts Chief of Market Development Position at Valencia Technologies 2
Cached News: